Latest

    Latest News

    MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions

    ICS announces first use of its Emblok system in Europe

    FDA approval for Viola clampless proximal anastomosis device

    Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death

    CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB

    Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials

    Data support use of AI to accurately estimate lesion-specific ischemia

    Inovise gains breakthrough designation for non-invasive heart failure management system

    Occlutech announces completion of enrolment in study of atrial flow regulator in heart failure patients

    CRT 2021: DISRUPT CAD III sub-study shows efficacy of IVL in patients with longer lesions

    Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences

    ACC.21 switches to a virtual-only meeting

    Urgent action needed to address growing burden of heart failure

    CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT

    Study shows AI can “extend the reach” of echocardiographic assessment

    OpSens gains CE mark for OptoWire III

    MRI study of COVID-19 patients with raised troponin levels reveals high rate of heart damage

    Teleflex completes enrolment in CTO-PCI IDE study

    Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease

    Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI

    Substantial reduction in tricuspid regurgitation reported in 30-day outcomes of CLASP TR study of Pascal device

    Off-pump CABG “an effective option” for patients with reduced ejection fraction

    Global heart failure cases soar since 1990

    New recommendations issued on antithrombotic treatment of AF patients undergoing PCI

    Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes

    First patient enrolled in SUCCESS PTA post-market study of Selution drug-eluting balloon

    iVascular announces availability of Angiolite DES for longer lesions

    Philips completes acquisition of cardiac diagnostics specialist BioTelemetry

    Puzzle Medical receives breakthrough designation for its transcatheter pump device

    First European patient treated with Diamondback 360 coronary orbital atherectomy system

    COVID-19 patients at greater risk of death after cardiac arrest

    Rate of target vessel failure “significantly lower” after IVUS-guided PCI

    Study documents “surprisingly benign” impact of COVID-19 among cardiac surgery patients

    everolimus

    Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs

    Comparative study reports favourable outcomes for VasoStat haemostasis device

    STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery

    STS 2021: Sean C Grondin elected STS president

    STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve

    STS 2021: Study identifies significant gender disparities in CABG

    STS 2021: Cardiothoracic surgery suffers due to COVID-19

    STS 2021: Study of Impella 5.5 reports 79% survival rate at explant

    Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI

    Ancora Heart enrols first patient in the CORCINCH-HF study

    EU patients enrolled in REVERSE-IT trial of bentracimab for reversal of antiplatelet effects of ticagrelor

    SIS Medical announces publication of results of ISAR-CALC study for its high-pressure balloon catheter

    Scoring systems may overstate risk of minimally invasive aortic valve procedures

    NHS England mandates adoption of HeartFlow analysis for coronary heart disease

    Study backs biopolymer used in Foldax’s Tria valve

    Alleviant Medical receives FDA breakthrough designation for transcatheter technology

    Aktiia’s wrist-mounted blood pressure monitor gains CE mark

    Social determinants key in assessing coronary heart disease risk

    Patients “fearful” of seeking cardiac care during pandemic

    “A huge loss to the cardiology community”: Tributes paid to Prof David Foley

    Diamondback 360 atherectomy system gains CE mark

    Elixir Medical announces treatment of first patient in BIOADAPTOR trial

    Abbott receives expanded Medicare reimbursement for MitraClip

    Occlutech’s atrial flow regulator receives breakthrough designation for heart failure patients

    Results from EXTRACT-PE trial of Penumbra’s Indigo aspiration system published

    “This is the tip of the iceberg” warns BHF as cardiothoracic surgeries cancelled

    iVascular announces 6mm maximum overexpansion capacity for Angiolite DES

    Complete revascularisation achieved in one quarter of patients with acute MI complicated by cardiogenic shock

    First remote robotic-assisted PCI completed in Europe using R-One platform

    The Foundry announces first-in-human procedure in study of Half Moon TMVR device

    Inari Medical’s FlowTriever receives FDA clearance for treatment of right atrial clot in transit

    Medtronic gets Health Canada approval for use of Evolut in low-risk aortic stenosis patients

    ACC.21 to offer remote COVID-19 screening

    CathWorks raises funds to support commercialisation of FFRangio system

    “Change in culture” needed to increase RCTs in cardiothoracic surgery

    David J Cohen joins CRF as director of clinical and outcomes research

    Acute heart failure patients see mortality risk double with COVID-19

    Ultromics receives FDA clearance for EchoGo Pro

    CorWave secures €35 million investment

    Heart failure specialist joins ALIVE Trial of Revivent transcatheter system

    VDYNE secures funding for studies of tricuspid valve replacement device

    Jian’an Wang named as editor of JACC: Asia

    First US patient treated in trial of Harpoon mitral valve repair system

    Sapien 3 valve approved for treatment of severe symptomatic aortic stenosis in Canada

    Abbott’s HeartMate 3 LVAD receives approval for paediatric use

    Analysis of STEMI patients finds little difference between prasugrel and ticagrelor after PCI

    New valvular heart disease guidelines recognise expanding role of TAVI

    MagicTouch SCB granted breakthrough designation for the treatment of small coronary artery lesions

    Investigational device exemption granted for Tria biopolymer mitral valve

    Paying patients less likely to develop complications after cardiac surgery

    Abiomed completes first stage in early feasibility study of ECP heart pump

    CardioFlux imaging system granted Breakthough Device Designation

    ACC partners with Amgen and Veradigm on TRANSFORM: ACS study

    Corindus announces global launch of technIQ procedural automation series for CorPath GRX system

    European launch for Acutus Medical’s AcQCross transseptal crossing system

    Leaders in cardiothoracic surgery to consider impact of COVID-19 on the field

    Abbott launches virtual reality training programme for cardiologists using OCT imaging technology

    Enrolment in Dan-NICAD II study of non-invasive diagnostic testing system completed

    Staged strategy may be associated with improved outcomes when treating mitral regurgitation post-TAVI

    Pre-existing coronary arterial disease linked to higher rate of myocardial infarction in patients receiving MitraClip

    LivaNova reaches agreement to sell its heart valve business

    Cathy Gates named as ACC’s new CEO

    Cardiothoracic surgery “stifled” during COVID-19 pandemic

    VersaCross RF Transseptal device found to be efficient for TMVR procedures

    Scoring system stratifies “dual” risk in aortic stenosis patients

    Woman patient

    Women face a higher risk of heart failure after STEMI

    Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor

    Philips launches IntelliSpace Portal 12 with updated cardiology imaging

    Gore announces encouraging early results for its pulmonary valved conduit

    PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure

    PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study

    PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement

    “Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation

    PCR Valves: “Encouraging” early results from DragonFly transseptal mitral valve presented

    PCR Valves: Valve-in-valve replacement should be standard of care for high-risk patients

    PCR Valves: EXPAND registry reports favourable outcomes compared to COAPT

    PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI

    Already the gold standard? PCR Valves panellists probe accumulating TAVI evidence

    Tributes paid following death of esteemed UK cardiologist Anthony Gershlick

    3D-printed heart model could be used in preparation for surgical training

    Corvia completes randomisation in REDUCE LAP-HF II trial

    Boston Scientific discontinues Lotus Edge TAVI device

    AHA 2020: Sinomed announces positive safety and efficacy data from PIONEER III study

    TAVI overtakes surgical aortic valve replacement in the USA

    AHA 2020: AF detected more often in high risk patients recovering from cardiac surgery

    AHA 2020: Patients taking statins experience similar side effects from placebos

    AHA 2020: One-month DAPT safe and feasible after stent placement

    AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI

    AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves

    Transcatheter repair strategy for tricuspid regurgitation associated with improved outcomes

    Append Medical completes transcatheter implant-free LAA occlusion procedures

    Higher risk in heart valve procedures performed by early-career cardiothoracic surgeons

    American Heart Association issues call for action on structural racism in cardiovascular care

    Results from Onyx One Clear study published

    First 1,000 patients treated with Impella 5.5 with SmartAssist

    England’s first COVID-19 lockdown led to a significant drop in PCI procedures

    Study draws link between physician payments and device selection

    AstraZeneca receives EU approval for heart failure drug Forxiga

    Ticagrelor may not be superior to clopidogrel in ACS patients undergoing PCI

    Recipients of MyoSeed research funding announced

    Heart failure patients with COVID-19 at increased risk of death, JACC study finds

    First patients treated with the Impella ECP heart pump

    Panel explores the unanswered questions around short duration DAPT

    Foldax receives US FDA approval to expand clinical study of novel biopolymer aortic heart valve

    ESC events to continue digitally in 2021, society announces

    BioCardia shares early data from phase III CardiAMP cell therapy trial

    Study assesses cardiac troponin elevation and presence of echocardiographic abnormalities in COVID-19 patients

    US FDA approval for Abiomed’s Breethe OXY-1 system

    Tricuspid annular dilatation predicts mortality in aortic stenosis patients undergoing TAVI

    ACC publishes consensus document on TAVI-related conduction disturbances

    Research programme to probe causes of unexplained cardiac arrest

    Meta-analysis supports use of all-cause mortality in PCI versus CABG trials

    JACC journal series looks at impact of COVID-19 on cardiovascular health

    OPTIMIZE IDE study of Svelte drug-eluting stent shared at TCT Connect 2020

    Biosensors gains CE mark approval for BioFreedom Ultra stent system

    TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial

    TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients

    TCT Connect 2020: SOLVE-TAVI shows higher rate of stroke for balloon-expandable valve

    TCT Connect 2020: Reduced mitral regurgitation achieved with next generation MitraClip

    TCT Connect 2020: Disrupt CAD III meets safety and effectiveness endpoints

    TCT Connect 2020: Philips announces one-year results of DEFINE PCI

    Mehran TCT 2020

    TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens

    TCT Connect 2020: MITHRAS trial finds interventional iASD closure non-superior to conservative therapy

    TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients

    TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial

    TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF

    High-risk surgery patients vulnerable to cardiovascular diseases

    TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system

    TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation

    Medtronic agrees to invest in TMVr device development

    TCT Connect 2020: PCI of non-flow-limiting vulnerable plaques is safe and enlarges follow-up lumen area

    Medtronic announces plans for head-to-head TAVI device study

    TCT Connect 2020: NuVera announces results from first-in-human study of ICE catheter

    Perceval sutureless valve data presented at EACTS 2020

    More randomised trials needed in cardiothoracic surgery, says EACTS president

    EACTS 2020: surgeons told to be wary of “creeping” rise of TAVI

    ACC announces collaboration on trial of Butterfly ultrasound system

    Development of AF after CABG linked to higher risk of cerebrovascular accidents at 10 years

    First patient implanted with next-generation AngelMed Guardian system

    ESC and EACTS to review left main coronary artery stenosis evidence

    EXCEL analysis supports protocol definition of procedural myocardial infarction

    Medtronic’s Resolute Onyx approved for one-month DAPT labelling by US FDA

    Study finds over 2,000 excess cardiovascular deaths in England and Wales during pandemic

    Cardiac Dimensions secures US$17.5 million series C financing

    Boston Scientific launches Acurate neo2 aortic valve system in Europe

    InnovHeart announces first-in-human use of its Saturn mitral valve

    Review looks at TAVI device selection and concludes head-to-head studies needed

    V-Wave closes US$98 million financing round

    Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices

    Recurrent heart attacks declining, but overall rate remains high

    Abbott receives CE mark for the next-generation Mitraclip

    IVUS linked to favourable PCI outcomes, but uptake is low

    TCT Connect 2020 to feature late-breaking interventional cardiology studies

    Aspirin-free monotherapy after coronary artery stenting is feasible and safe

    VitalConnect begins TELESTAR-TAVR remote monitoring study

    AHA calls for awareness of medication-induced arrhythmias

    Cardiac MRI effective at identifying myocarditis in athletes

    Older patients “unaware” of heart valve disease risks

    TIDES-ACS confirms performance of Hexacath’s titanium-nitride-oxide coated stent

    Medtronic begins early feasibility study of the Intrepid transcatheter valve system

    Patient-specific, 3D printed aortic valve model used in preparation for TAVR procedure

    Cardiac Dimensions receives Australian regulatory approval for its Carillon mitral contour system

    Fujifilm Sonosite receives FDA clearance for COVID-19 use of its cardiac ultrasound systems

    Japan and the USA see an increase in PCI procedures

    First patient enrolled in TRANSFORM-1 study of MagicTouch DCB

    CryoLife acquires Ascyrus Medical

    ACC announces revised dates for ACC.21

    BioVentrix resumes ALIVE trial after COVID-19 pause

    ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients

    ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG

    Philips launches latest version of its Azurion imaging platform

    Miracor secures financing to support PiCSO clinical study

    ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function

    ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy

    ESC Congress 2020: Mavacamten improves heart function in HCM patients

    ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling

    ESC Congress 2020: Society publishes new guidelines on congenital heart disease, non-ST-segment elevation ACS

    ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin

    FDA approves revised labelling for Medtronic’s Evolut valve

    CX Aortic Vienna

    Inaugural CX Aortic Vienna to take place online

    Philips expands cardiovascular ultrasound portfolio with Affiniti CVx

    AHA issues guidance on stroke prevention in heart surgery patients

    Heart Rhythm Society publishes Cardiovascular Digital Health Journal

    Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic

    Heart teams and interventional cardiologists often differ over recommendations for multivessel CAD

    Women “underrepresented” in heart failure studies

    Transcatheter tricuspid valve replacement “low risk” for complications

    Philips introduces Omniwire for coronary artery procedures

    Cardiovascular risk factors linked to COVID-19 complications and death

    10-year data on VIVO ISAR drug-eluting stent published in JACC

    Stress may have clinical implications for heart failure patients

    Biosensors announces enrolment of first patient in REFORM pivotal trial

    Survey reveals patient attitudes to heart valve procedures

    InnovHeart secures US$24 million finance package

    JAHA retracts paper calling for end to cardiology diversity programmes

    FORWARD PRO study of Evolut Pro valve meets safety and efficacy goals

    CardioMech secures financing for mitral valve repair study

    Meta-analysis advocates “personalised approach” to DAPT duration after PCI

    Eko and AstraZeneca announce digital cardiovascular health partnership

    FDA issues EUA for left-sided Impella to provide left ventricular unloading

    Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients

    Japanese study finds high survival rates with use of Impella heart pump

    Low one-year rate of mortality found in mitral valve-in-valve replacement using Sapien 3

    Keystone Heart announces first case using TriGUARD 3 CEP device

    NSAIDs increase bleeding risk after myocardial infarction, Korean study finds

    American College of Cardiology to launch JACC: Asia

    Abiomed gains approval for data streaming from the Impella console

    TAVI or surgical valve replacement “similarly effective” in men and women

    Caption Health gains FDA approval for updates to its cardiac AI system

    Mavacamten granted Breakthrough Therapy Designation

    Funding secured to further study of AI systems for cardiovascular health

    Genetic testing could aid decision-making in cardiovascular healthcare

    Race and gender bias may impact the timing of treatment for heart failure patients

    Inspiron sirolimus eluting stent receives CE mark approval

    Next-generation Watchman LAAC device gains US FDA approval

    LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

    LivaNova launches Perceval Plus sutureless heart valve in Europe

    Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome

    Fall in hospitalisations for acute coronary syndrome seen during COVID-19

    FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

    AHA Scientific Sessions 2020 to be held virtually

    Half of COVID-19 patients receiving echocardiograms show heart abnormalities

    FDA grants Breakthrough Device Designation for Doraya temporary catheter

    ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter

    Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market

    EAPCI issues consensus statement on ischaemia with non-obstructive coronary arteries

    First 10-year report of TAVI durability indicates a low rate of structural valve deterioration

    Data on Paragonix SherpaPak cardiac transport system in complex heart transplants released at American Transplant Congress

    First coronary patient enrolled in FDA IDE study of drug eluting balloon

    Woman patient

    Black patients have higher rates of death after PCI

    Ancora Heart receives IDE approval for study of AccuCinch

    American Heart Association appoints Mitchell Elkind as president

    NuVera announces successful first-in-human use of NuVision ICE catheter

    A higher volume of mitral valve repair procedures is associated with lower mortality rates

    Morning exercise is the key to a good night’s sleep after heart bypass surgery

    Carag Bioresorbable Septal Occluder approved for US IDE trial

    PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”

    PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI

    PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device

    MedAlliance gains CE mark for coronary Selution SLR sirolimus drug eluting balloon

    CardiAMP Heart Failure Trial continues with first patient randomised in Covid-19 era

    PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

    PCR e-Course 2020: Data for Ultimaster reinforce safety and efficacy of device

    PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than tirofiban in STEMI patients

    PCR e-Course 2020: CoFI system may address microvascular obstruction after primary PCI

    PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients

    PCR e-Course 2020: Routine revascularisation confers no survival advantage over initial medical therapy in patients with stable disease

    PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair is sustained at one year

    PCR e-Course 2020: DynamX Bioadaptor shows “excellent” safety and efficacy at 12 months

    PCR e-Course 2020: DEFINITION II finds two-stent approach better than provisional in complex lesions

    PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure

    PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective

    First evaluation of long-term outcomes after aortic valve-in-valve presented at PCR e-Course 2020

    PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via a transseptal approach

    PCR e-Course 2020: Mitral valve-in-valve and valve-in-ring strategies often require repeat procedures

    ACC and SVS Join Forces on Single Vascular Registry

    Miracor Medical’s PiCSO System receives CE mark

    Evolut gets CE mark in low-risk patients and new labelling for bicuspid use

    Smartphone app uses can identify lung congestion in heart failure patients

    Proximo Medical and Coala Life announce partnership for US markets

    Abiomed initiates online education platform for PCI

    IC fellows’ training has been affected by pandemic

    Blue Sail Medical and Biosensors International acquire TAVI company NVT

    MicroPort obtains CE mark for PathBuilder

    British Heart Foundation calls for urgent resumption of routine services for heart and circulatory diseases

    FDA issues IDE for Impella ECP and EUA for Impella RP

    Keith Oldroyd to become CMO at Biosensors

    A coordinated strategy provides the best outcomes for aortic arch treatment

    Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

    Bicuspid TAVI outcomes as good as those for tricuspid

    ACC launches summer COVID-19 education series

    ESC to stream the latest science in heart failure

    EXCEL: PCI inferior to CABG in Bayesian reanalysis

    PERSIST-AVR study on Perceval sutureless aortic valve presented at AATS

    CeloNova completes enrolment in first 14-day DAPT randomised controlled trial

    COVID-19: TCT becomes latest conference to go virtual

    Limited health literacy associated with a higher risk of death in heart failure patients

    Society of Cardiovascular Computed Tomography to present gold medal award to John Lesser

    COVID-19: NHS staff show signs of mild depression

    SCAI 2020: PROTECT III shows placing Impella prior to high-risk PCI associated with lower mortality

    Jeffrey J Popma joins Medtronic as vice president and chief medical officer for coronary, renal denervation, and structural heart businesses

    CE mark PASCAL clip-based system for transcatheter tricuspid repair

    Robotic PCI associated with a 20% reduction in radiation exposure

    SCAI 2020: Strong 10-year performance for Melody transcatheter pulmonary valve

    Risk factors for cardiovascular disease linked to cognitive decline

    Eating is no less safe than fasting prior to cardiac catheterisation

    SCAI 2020: Statin therapy plus icosapent ethyl significantly reduces number first and repeat revascularisation

    SCAI 2020: Telemedicine could be used offer remote guidance to STEMI patients

    PCR announce dates for its online course

    SCAI release positional statement on optimal PCI for complex coronary artery disease

    MedAlliance gains CE mark approval for coronary Selution SLR balloon

    Cardiothoracic surgeons are “extremely satisfied” with their jobs

    COVID-19: NCDR Chest Pain-MI, CathPCI registries to review effect of virus on heart disease patients

    Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications

    FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

    Resolute Onyx matches Orsiro at two years in all-comers’ patients

    COVID-19: Heart Valve Voice US raises concerns about lack of patient input in recent guidance on restarting elective procedures

    COVID-19: Mayo Clinic works with Ultromics to rapidly assess patients with COVID

    Positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy for heart failure

    COVID-19: Anticoagulants may improve survival among hospitalised COVID patients

    Boston Scientific announces positive PINNACLE FLX study results

    COVID-19: Survey suggests increased operating days may be required to clear elective backlog

    COVID-19: ESC Congress 2020 to become a completely virtual event

    Study establishes safety and efficacy of ticagrelor monotherapy in acute coronary syndrome patients treated with Orsiro

    CE mark for SuperSaturated oxygen therapy

    COVID-19: Society of Cardiovascular Computed Tomography to host virtual meeting

    COVID-19: North American societies provide advice on resuming cardiovascular procedures

    complete-revascularisation

    The top three symptoms of myocardial infarction are same for women and men

    LifeSignals receives CE mark for the ECG Remote Monitoring Patch

    Wearable necklace-ECG can detect abnormal heart rhythm

    COVID-19: PCR officially cancel EuroPCR 2020

    Multivessel PCI has similar outcomes to culprit-vessel only PCI for cardiogenic shock patients when mechanical circulatory support used

    COVID-19: Calls for physicians to address domestic violence during social distancing

    Abiomed acquires novel ECMO developer Breethe

    American Academy of Neurology recommends PFO closure for selected stroke patients

    COVID-19: CMS outlines recommendations for restarting non-emergent procedures

    Cardiovascular robotics company secures €40 million series C financing round

    iRhythm offers home enrolment of Zio monitoring devices

    Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

    COVID-19: SCAI and CAIC launch registry to provide vital data for managing patients

    COVID-19: BHF and NIHR work together to understand why cardiovascular increases risk of virus

    FDA Breakthrough Device Designation for novel heart failure therapy

    COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

    COVID-19: US societies release joint consensus statement on treating myocardial infarction during the pandemic

    COVID-19: Ventilator manufacturers unite to training alliance and create app for frontline workers

    COVID-19: Terumo BCT’s Mirasol shows efficacy against virus in plasma and platelets

    Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

    Proximo Medical named as commercialisation partner for Elucid Bioimaging

    COVID-19: Testing for high-sensitivity cardiac troponin would be beneficial not a hindrance

    COVID-19: “Essential” vs. “non-essential” TAVI procedures can be difficult to determine

    Study affirms safety and efficacy of Optimizer system for heart failure

    Pressing on abdomen helped to improve “STEMI” symptoms in rare case

    COVID-19: FDA authorise blood purification device for treating virus

    Woman patient

    COVID-19: Nearly 40% drop in STEMI cases in US cath labs since March 2020

    COVID-19: American Heart Association issue pandemic CPR guidelines

    COVID-19: Cotton and surgical masks may be ineffective at stopping spread of virus through coughs

    COVID-19: Both ACC and ESC urge patients to seek help if they experience symptoms of a myocardial infarction

    CE mark for transcatheter system that uses same clip technology as MitraClip

    US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19

    Philips and the US government collaborate in ventilator production ramp up to combat COVID-19 pandemic

    Mardil Medical completes treatment of third patient in VenTouch device trial

    Shockwave completes enrolment in study of coronary intravascular lithotripsy

    Webinar: Cardiovascular specialists detail COVID-19 strategies

    AHA issues oxygenation and ventilation guidance for healthcare providers

    Decreased ACE2 levels found in ageing and cardiovascular disease can increase likelihood of severe COVID-19

    COVID-19: Edwards pauses enrolment in mitral and tricuspid trials to allow hospitals to focus on virus

    COVID-19: European Commission agrees to postpone new MDR because of pandemic

    Athena Poppas begins ACC presidency

    PPE guidance for cardiology during COVID-19 pandemic operating in a “vacuum” in UK

    CMSS

    CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected

    Raised troponin and interleukin-6 levels are associated with a poor prognosis in COVID-19

    Italy, USA and the UK share their cardiology COVID-19 experiences in LIVE Webinar

    Cardiologists share COVID-19 insights

    ACS defends healthcare workers as PPE shortages lead to acrimony

    Daniel M Philbin Jr named new chair of the ACC board of governors

    Live webinar on Thursday 2 April to share COVID-19 cardiovascular experience

    Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement

    Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

    Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease

    MitraClip in moderate surgical risk patients

    Virtual ACC: Newer generations of MitraClip associated with greater reduction in mitral regurgitation than previous version

    Virtual ACC: Use of radial artery in heart bypass surgery improves patient outcomes

    Onyx One Clear Study

    Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

    Virtual ACC: Clopidogrel exposure along with aspirin and rivaroxaban should be “minimised or avoided” in PAD revascularisation

    Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients

    Michael Bohm

    Virtual ACC: Renal denervation bests sham control to safely lower blood pressure in patients with untreated hypertension

    Virtual ACC: Largest left atrial appendage occlusion registry finds Watchman acute safety data “very encouraging”

    Virtual ACC: Antiplatelet drugs increase risk for TAVI patients with atrial fibrillation

    Virtual ACC: Low-dose colchicine after myocardial infarction is “economically dominant”

    Virtual ACC: Combining aspirin with rivaroxaban provides greater absolute risk reduction in diabetes

    Virtual ACC: Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularisation

    Virtual ACC: Genotype-guided therapy after PCI does not hit study target

    COVID-19: European Commission looking to postpone new MDR by one year

    Adapt clinical studies to alleviate effect of pandemic

    Cardiac injury in COVID-19 patients linked with higher death rate

    CDRH adjusts working practices with medical device companies to deal with COVID-19

    AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

    BCIS and BCS ratify NHS guidance for cardiology during COVID-19 pandemic

    SCAI launches web section devoted to COVID-19 updates and cancels Scientific Sessions

    Duo device for tricuspid repair records first successful use in humans

    New guideline: ASA no longer recommended to prevent first stroke, heart disease

    One-third of critically ill COVID-19 patients in Washington State series developed cardiomyopathy

    FDA issues new policy on remote monitoring devices for use during COVID-19 pandemic

    First report gives insight on impact of COVID-19 in heart transplant patients

    ageing mitral valve surgery

    Frailty predicts greater death rate and higher costs after mitral valve surgery

    SCAI issues advice for cath labs in light of COVID-19 pandemic

    Transcatheter heart valves are overlapping with coronary arteries

    TriGUARD 3 given CE mark for embolic protection during TAVI

    Portola Pharmaceuticals unveils data on Andexxa in patients with multiple types of Factor Xa inhibitor-related bleeds

    Early quality of life increases or benefits in COAPT translate to better long-term clinical outcomes

    PCI for chronic total occlusion less successful after bypass surgery

    ACC.20/WCC will be a virtual meeting

    Long-term exercise may lead to aortic enlargement and remodelling

    Abbott receives CE mark for FlexNav delivery system

    New England Journal of Medicine to review EXCEL data

    Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments

    CryoLife given CE mark for On-X Ascending Aortic Prosthesis

    FDA issues update on reducing the risk of patient infections during cardiac surgery

    First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system

    Heart Research UK awards grant to University of Leeds to develop new heart failure treatments

    CRT 2020: TAVI safe at 30 days in low-risk bicuspid aortic stenosis

    CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality

    CRT 2020: Biotronik reports three-year results for Orsiro DES from BIOFLOW-V trial

    Append Medical share clinical proof-of-concept results for internal sealing of LAA

    Edwards Life sciences initiative

    Edwards expands its Every Heartbeat Matters initiative

    Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI

    Ablative Solutions publishes data from the Peregrine post-market study

    Cardiovalve

    Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system

    BBC Newsnight makes fresh claims about allegedly withheld mortality data in EXCEL

    VitalConnect adds arrhythmia detection to its remote monitoring software

    JIM 2020: Weigh up early and late events in EXCEL to determine treatment for left main disease

    AI-guided cardiac imaging system given FDA authorisation

    Orsiro Mission DES

    Orsiro Mission gets CE mark

    Philips iFR Coregistration SyncVision

    Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray

    Germany renews Revivent’s NUB reimbursement status 1 for 2020

    CABG shows 10-year benefit over PCI in left main patients with high SYNTAX score

    Medtronic begins pilot study as part of SPYRAL HTN clinical programme for renal denervation in hypertension patients

    FDA Breakthrough Device Designation for fully implantable left ventricular assist system

    Portola Pharmaceuticals appoints Rajiv Patni as executive vice president and chief medical officer

    Guy’s and St Thomas’ to merge with Royal Brompton & Harefield NHS Foundation Trust

    Abbott becomes first company in world to have transcatheter mitral implantation device on market

    STS 2020: Harness the power of Twitter to give your research greater impact

    Biotronik

    Biotronik appoint company’s first chief medical officer

    STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI

    STS 2020: Enhanced surgical recovery protocols will allow safe three-day discharge

    distal

    New randomised study investigating distal radial access, DISCO RADIAL, launches

    Low albumin, anaemia, and slow walking speed predict mortality after TAVI

    First patient enrolled in PREDICT-LAA clinical trial

    SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

    Emboline completes enrolment in SAFEPASS 2 clinical trial

    BioCardia gets FDA clearance for catheter to guide Helix delivery system

    Davide Capodanno, Gilles Montalescot, Marco Valgimigli and Dirk Sibbing

    Spartan Bioscience sets up European advisory board for precision medicine test in cardiac stent patients

    EXCEL finds repeat revascularisations following both CABG and PCI lead to increased mortality

    STS says independent analysis of EXCEL is best opportunity to “get it right for patients”

    ACC makes senior staff appointments

    Abbott gets green light for trial on MitraClip in moderate surgical risk patients

    Self-expanding valves show good haemodynamic performance in small annuli

    FDA approves Abbott heart pump for less invasive surgical approach

    Jean-Claude Dubacher named chairman and CEO of B Braun Medical

    Proximo Medical to partner with CeloNova Biosciences

    EXCEL: EACTS reaches out to trial investigators to “resolve concerns”, as CRF commissions independent review

    EXCEL: EACTS explains its decision-making on left-main guidelines, and AATS calls for all data to be published

    Corresponding author Evald Hoj Christiansen

    NOBLE finds PCI inferior to CABG at five years in left main disease

    EACTS and STS announce strategic partnership

    FDA grants Breakthrough designation for ECG-based algorithm

    The results of the safety profile and efficacy of Lixiana study

    European trial data ‘reinforce’ safety profile and efficacy of Lixiana

    impella in preventing heart failure in stemi patients

    New trial to evaluate role of Impella in preventing heart failure in STEMI patients

    EXCEL leadership refute BBC Newsnight claims in 3,500-word document

    Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

    BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease

    InnovHeart appoints Brent Ratz as independent member of the board

    Bioventrix announces positive one-year outcomes for Revivent TC system

    Enrolment completed for MASTER DAPT trial

    AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease

    AHA 2019: Preprocedural COLCHICINE-PCI finds a lowering of inflammation, but no reduction in myocardial injury

    PCR London Valves 2019: Meril unveils positive data for Myval

    Corindus completes first transcontinental simulated telerobotic PCI procedures over 5G, fibre, and public internet networks

    Revivent transcatheter system receives Breakthrough Device Designation from the FDA

    PCR London Valves 2019: PARTNER 2 analysis shows Sapien 3 valve as durable as surgical valves at four years

    PCR London Valves 2019: TRILUMINATE shows safety and efficacy of TriClip maintained at one year

    PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI

    AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor

    PCR London Valves 2019: One-year survival better with Mitra Clip than with medical therapy among COAPT-excluded patients

    Shockwave commences IVL study to support regulatory approval in Japan

    “Cuffless” system to monitor blood pressure could replace traditional methods

    Multiphase and early systolic phase CT screening in TMVR superior to end systole analysis at predicting obstruction risk

    GLOBAL LEADERS: no sex-difference in mortality or MI rates two years after PCI, but bleeding risk higher in women than men

    Left atrial appendage closure associated with a decreased stroke risk in AF patients

    Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients

    US FDA grants Breakthrough Device designation to CorFlow Infusion System

    Cardionovum’s coronary DCB receives regulatory approval in China

    Corindus’ stockholders approve acquisition by Siemens Healthineers

    Two further studies support three-month DAPT following PCI

    Patients with angiographically-intermediate coronary lesions

    Diversity strategies in cardiology are not working, study finds

    patient deaths are under reported said Rita Redberg

    Device deaths are under reported, says research letter

    VEST external stent demonstrates low event and disease rates in two prospective trials

    Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

    Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe

    Admedus sells CardioCel and VacsuCel to focus on TAVI

    Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels

    Douglas Drachman named as next vice chair of American College of Cardiology’s Annual Scientific Session

    EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

    Abiomed announces PROTECT III clinical data for protected PCI with Impella

    AccuCinch ventricular repair system associated with favourable safety profile at 30 days

    TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI

    CE mark granted to the Gore Cardioform ASD Occluder for the treatment of atrial septal defects

    Endotronix closes expanded series D financing round of US$70 million for Cordella

    TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT

    TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route

    TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term

    TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective

    TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3

    TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems

    TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI

    FDA approves Evolut PRO+

    Boston Scientific announces schedule of presentations at TCT 2019

    Corindus showcasing CorPath GRX system at TCT 2019

    Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation

    merit-medical-radial-compression

    Merit Medical unveils PreludeSYNC EVO radial compression device

    ESC 2019: Registry study supports use of ICDs for primary prevention in patients with heart failure

    ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

    ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients

    ESC 2019: Left atrial appendage closure is non-inferior to NOACS for preventing major neurological, cardiovascular, and bleeding events

    complete-revascularisation

    ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention

    ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

    ESC 2019: Abiomed launches Impella SmartAssist platform

    Low-dose polypill could be used for primary prevention of cardiovascular events

    FARXIGA meets primary endpoint in Phase III DAPA-HF trial

    CeloNova appoints new president and CEO

    FDA approves new device to improve symptoms in patients with advanced heart failure

    FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

    Announcing the TCT 2019 late-breaking trials and science

    wirion

    Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

    Transcatheter repair of tricuspid valves appears safe and effective when surgery is not an option

    Hormone therapy linked to heart fat and hard arteries

    SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

    xarelto rivaroxaban

    Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

    Age alone should not preclude TAVI in patients aged ≥90 years

    Unfilled prescriptions for PCSK9 inhibitors lead to higher rates of cardiovascular events

    Medtronic enters into AI partnership for stroke care

    TARGET BP I trial enrols its first patient

    Edwards Lifesciences to discontinue its self-expanding valve Centera

    Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

    Fourth-generation MitraClip receives FDA approval

    Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease

    SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

    Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

    Medtronic announces global registry of HVAD thoracotomy implants

    FEops HEARTguide wins CSI Highlight of the Year Award

    Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

    MeRes100 BRS demonstrates sustained safety and efficacy

    Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold

    PASCAL poised to rival MitraClip for safety and efficacy

    NICE issues recommendations on insertion of cerebral protection devices during TAVI

    Zoll Medical acquires TherOx

    Patent granted to Valfix Medical for its percutaneous valve and replacement technology

    Robotic PCI company adds interventional cardiology experts to its medical advisory board

    Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems

    India-designed Myval associated with no device-related mortality at one year

    Mentice and Siemens Healthineers aim to bring a virtual patient to the angio-suite

    Nearly 50% of treatment strategies would change with use of investigational HeartFlow planner

    DSM and SAT enter partnership to develop the first next-generation heart valve

    CMS’ update to coverage policy for TAVI provides greater flexibility for hospitals and providers

    New trial to compare Watchman FLX to direct oral anticoagulants

    US$170m funding for Acutus Medical

    SCAI document provides advice on cath labs’ financial viability

    TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

    TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation of transcatheter heart valves “safer and more efficient”

    TVT 2019: TAVI is “preferred therapy” for low-risk patients

    Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership

    Cardiologists can help to avert nuclear doomsday

    PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS

    Early treatment with Helix system improves ejection fraction and symptoms

    Biotronik announces positive data for Magmaris

    FDA approves Cardioform ASD Occluder for the treatment of atrial septal defects

    American College of Cardiology names its first director of diversity and inclusion

    Philips launches IntraSight interventional applications platform

    Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

    Medtronic launches Telescope guide extension catheter

    EuroPCR 2019: VIVALL pilot study shows promise for safe use of Allegra heart valve in bioprostheses

    EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective

    EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR

    EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

    EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

    EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary syndrome

    Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR

    ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations for its PleuraFlow system

    Randal J Thomas looks to home-based cardiac rehabilitation

    USA needs to put greater emphasis on home-based cardiac rehabilitation

    Keith Dawkins appointed as chief medical officer at Shockwave Medical

    Avance steerable introducer given FDA 510(k) clearance

    Cordis expands its interventional cardiology portfolio with full US launch of radial products

    impella in preventing heart failure in stemi patients

    FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps

    Majority of cath labs feel burdens of PCI public reports outweigh benefits

    Less than half of vein graft interventions use embolic protection

    Triage STEMI patients for ICU after PCI based on reperfusion timing

    Vitros high-sensitivity troponin assay receives CE mark

    NeoChord raises additional financing to drive catheter‐based programme development

    Biotronik launches PK Papyrus covered coronary stent in the USA

    Virtue SEB given breakthrough device designation by FDA

    Bardy Diagnostics announces $35.5M funding injection

    Lotus Edge becomes third TAVI device on US market

    US FDA approve SSO2 Therapy for the management of myocardial infarction

    TAVI company Tioga Medical closes US$15M in series A financing

    PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal of the antiplatelet activity of ticagrelor

    Targeted blood pressure management helps to reduce strokes in patients with HVAD

    CE mark for the FEops HEARTguide

    Comics may help patients to better understand coronary interventions

    Prevalence of multiple organ failure among cardiogenic shock patients has steadily increased

    ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia

    RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

    Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

    Richard Kovacs assumes presidency of the American College of Cardiology

    ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

    CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

    CRT 2019: Alert system is safe, quick, and has few complications

    MitraClip in moderate surgical risk patients

    MitraClip can be used to treat secondary mitral regurgitation in the USA

    Micro Interventional Devices enters strategic alliance with Oscor

    CardioCel 3D and VascuCel receive regulatory approval in Europe

    ACC to offer transcatheter valve certification to help hospitals implement best practices

    CE mark for Watchman FLX left atrial appendage closure device

    Scott Gottlieb resigns as head of US FDA

    CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial

    CRT 2019: Early resorption and low complications demonstrated for Magmaris

    Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

    Woman patient

    Myocardial infarction patients taken directly to heart centres have better long-term survival

    CRT 2019: Three-year data shows trend towards lower target vessel failure with Orsiro vs. Resolute Integrity and Synergy

    CRT 2019: US FDA approves resting full-cycle ratio for measuring severity of coronary artery blockages

    CX 2019 to host first-ever aortic and peripheral virtual reality live cases

    Polymer-free stents have similar performance profiles, except in diabetes

    Sapien 3 provides safe and satisfactory access via the transcarotid route

    MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

    New Australian research and development partnership aims to innovate heart failure care

    American College of Cardiology to launch new journal dedicated to cardio-oncology

    Augmented reality surgical technology unveiled by Philips and Microsoft

    US physicians can now use Resolute to treat chronic total occlusions

    CE mark for R-One robotic-assisted solution for treating coronary diseases

    FDA approves Orsiro for use in the USA

    iVascular receives CE mark for Navitian microcatheter